Pulmonary and critical care: from the daily briefing
Every daily briefing item tagged pulmonary and critical care, newest first. The weekly roundup is on the pulmonary and critical care page.
- FDA classifies radiology software for referral of fibrotic lung disease findings into class IIRegulation
- FDA classifies over-the-counter devices to assess sleep apnea risk into class IIRegulation
- Lancet PROSpect trial compares prone positioning and high-frequency oscillation in early pediatric ARDSEvidence
- E-cigarettes nearly double 6-month quit rates even without counseling, and phone support doubles them again, NEJM Evidence trial findsEvidence
- Round-the-clock tele-ICU coverage cut hospital stays by 1.7 days at four safety-net hospitals without in-house intensivistsEvidence
- Adding pembrolizumab to SBRT does not significantly improve event-free survival in inoperable early NSCLCEvidence
- Azithromycin not associated with new nontuberculous mycobacterial isolation in bronchiectasis or COPDEvidence
- Abiomed Automated Impella Controller units recalled for hardware, firmware or software updatesIncident
- Human metapneumovirus tied to ICU admission, ventilation and in-hospital death in meta-analysis of 94 studiesEvidence
- Retatrutide reduces apnea-hypopnea index in obstructive sleep apnea with obesity in phase 3 trialsEvidence
- Efzofitimod tested as a steroid-sparing agent in pulmonary sarcoidosis in phase 3 trial of 331 patientsEvidence
- European intensive care society issues consensus statement on human-centred partnership in the ICUEvidence
- Neoadjuvant durvalumab plus chemotherapy reaches 74.6% resection rate in resectable lung cancer, phase 2 trialEvidence
- FDA adds five Olympus devices, including a capsule endoscope and two bronchovideoscopes, to an import block and posts a warning letterRegulation
Latest news
Tagged pulmonary and critical care, from the daily briefing